StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health Board-Approved Share Repurchase Authorization Remaining by Quarter

Board-Approved Share Repurchase Authorization Remaining ($M)

QuarterlyAnnual

Elevance Health Board-Approved Share Repurchase Authorization Remaining: $5,007M in Q3 2026, down 30.1% from a year earlier.

Latest, Q3 2026
5,007
Period ended Sep 30, 2026
Change on a year earlier
-30.1%
7,166 in Q3 2025
History
46 quarters
Since Q1 2015
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 (2026-09-30): 5,007,000,000.00”

Source: ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBoard-Approved Share Repurchase Authorization Remaining ($M)Year on yearSource
Q3 2026Sep 30, 20265,007-30.1%ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q2 2026Jun 30, 20265,337-33.6%ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q1 2026Mar 31, 20265,571-33.8%ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q4 2025Dec 31, 20256,695-28.0%ELV 10-K (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q3 2025Sep 30, 20257,166+130.3%ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q2 2025Jun 30, 20258,041+153.6%ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q1 2025Mar 31, 20258,420+131.8%ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q4 2024Dec 31, 20249,300+121.4%ELV 10-K (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q3 2024Sep 30, 20243,111-39.3%ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q2 2024Jun 30, 20243,171-43.5%ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q1 2024Mar 31, 20243,633-41.9%ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q4 2023Dec 31, 20234,200+123.9%ELV 10-K (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q3 2023Sep 30, 20235,128+109.8%ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q2 2023Jun 30, 20235,608+85.6%ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q1 2023Mar 31, 20236,254+71.5%ELV 10-Q (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗
Q4 2022Dec 31, 20221,876-55.2%ELV 10-K (XBRL us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1) ↗

Cite this data

StockData. (2026). Elevance Health Board-Approved Share Repurchase Authorization Remaining ($M), quarterly Q1 2015–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/buyback-authorization-remaining

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.